PNC-27_Dosage, benefits & legal status
Also known as PNC27, PNC-27 peptide, p53-MRP peptide
A lab-designed peptide with big cancer claims and no human trial in 25 years.
Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.
What is PNC-27?
Plain language first. The technical label stays, but it never stands alone.Overview
The theory is careful and interesting, and it has never been tested in a person.
PNC-27 is a peptide built in a lab that is sold with claims about killing cancer cells. The idea behind it is real science: many cancer cells carry a protein called HDM-2 on their outer surface, and most healthy cells keep it tucked inside. PNC-27 was designed to stick to that protein and punch holes in the cell.
What it's used for
Sold online with anti-cancer claims. It has only ever been studied in cells and mice.
How does PNC-27 work?
What it does in the body, and where.The theory behind PNC-27 is genuinely clever, and it is worth understanding so you can see exactly where the evidence stops.
- 01Many cancer cells put a protein called HDM-2 on their surfaceHealthy cells make the same protein but keep it inside. That difference is what the whole design rests on.
- 02PNC-27 carries the piece of p53 that grabs HDM-2p53 is the body's own tumour-suppressing protein. Researchers copied the part of it that docks onto HDM-2.
- 03Once anchored, it opens a hole in the membraneThe cell spills its contents and dies. In lab dishes this happened to cancer cells and not to normal ones.
- 04Nothing after this step has been tested in a personEvery published result is from cells in a dish or from mice, and nearly all of it comes from the one laboratory that designed the peptide.
What else is it used for?
Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.
- Killing cancer cells in a dish, which it does reliably in published lab workEarly research
- Shrinking tumours in mice, reported by the group that designed itEarly research
- Treating cancer in a person, which has never been testednone
How much, and do you cycle it?
The range, and whether you take breaks.Research only, varies. No established patternNo range
Nothing is known about how long it stays in a person or what repeated doses do.
How long does it stay in the body?
The half-life, and where the figure comes from.Nothing publishedNo figure
Nothing published. A patent assumes the figure is measured in minutes without measuring it.
You can compare this against the whole library to see where it sits.
How do I dose and price it?
Enter your vial and your dose. Pick a mix. We show the draw and the cost.The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.
Choose your mix
Measuring the water1 mL = one full 100-unit syringe.
Your draw
0 / 100 unitsPNC-27 starts at $79.00 across 7 vendors, typically $11.90 – $28.40 per mg.
8 listings, last read Aug 27, 2026. Shipping and card fees are not included.
How do you store it?
Before mixing, and after.Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.
Unmixed lyophilized PNC-27 keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.
What are the side effects and cautions?
Known cautions and warnings for this compound.If you or someone you care about has cancer, talk to an oncologist before considering anything you read about this peptide. Delaying or replacing treatment that works is the real risk here, and it is a much bigger risk than anything in the vial. There is no established dose because no dose has ever been tested in a person.
Who should avoid it
- Anyone with cancer who is using it in place of, or alongside, real treatment without telling their oncologist
- Pregnancy
- Anyone expecting it to do what the marketing says, since no human evidence exists
Stop and get help
- Any reaction at all, since there is no safety record to compare against
- Signs of an allergic reaction such as face or throat swelling, hives, or trouble breathing
Common effects
- Unknown. No human study has recorded what happens to a person taking this.
- In cell studies it kills cells by bursting them open, which is a messier form of cell death than most cancer drugs cause. What that means in a body is untested.
Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.
Is PNC-27 approved?
And where the numbers on this page come from.No. PNC-27 is not approved for any use, anywhere. It is sold labelled for laboratory research only, and there is no legal route to buy it for human use.
- Approval statusResearch only
- RouteUnder the skin (subcutaneous)
- CheckedAugust 2026
What has happened recently
Not approved anywhere and never tested in a human trial. It appears in the National Cancer Institute drug dictionary, which records compounds with proposed activity and is not an endorsement or a sign of approval. Vendor pages sometimes cite that listing as if it were. The peptide was designed around the year 2000, so the absence of a trial after twenty-five years is itself information.
You can compare this against the whole library, or read how to check a seller.
- DoseFrom research and community reports. No regulator has reviewed this dose.
- Vial sizeFrom what vendors typically list; not a recommendation.
- Sources
- Reviewed14 August 2026
What else is like PNC-27?
Others in Longevity and energy, side by side.If you're weighing PNC-27, it's worth reading N-Acetyl Epitalon Amidate, Cardiogen, and SHLP2 in the same class.
A lab-designed peptide with big cancer claims and no human trial in 25 years.
- Dose
- Research only
- How often
- Varies
A longer-lasting version of Epitalon, with no study of its own.
- Dose
- Research only
- How often
- 10-20 day courses
A lab-made 4 amino acid peptide aimed at the heart muscle.
- Dose
- Research only
- How often
- Daily, in 10-20 day courses
A mitochondrial peptide with real published biology and no human dosing behind it.
- Dose
- Research only
- How often
- Not established
10What these words mean
Show glossary +
What these words mean
- 503A and 503B
- The two kinds of compounding pharmacy in US law. A 503A pharmacy prepares medicine for one named patient. A 503B outsourcing facility makes larger batches under stricter manufacturing rules.
- Agonist
- Something that switches a receptor on. The opposite is an antagonist. It blocks the receptor instead.
- Amino acid
- The building blocks that link together in a chain to make a peptide or a protein. The order they sit in is what makes one peptide different from another.
- Amylin
- A hormone released alongside insulin that slows the stomach emptying and reduces appetite. Several weight loss compounds copy it.
- Analog
- A compound built to copy a natural one with small deliberate changes, usually so it lasts longer or holds onto its target more tightly.
- Animal study
- Research done in rats, mice or other animals. Most findings do not repeat in people, so an animal result is a reason to keep looking. It is not a reason to act.
- Antibody
- A large immune protein, far bigger than a peptide, engineered to lock onto one specific target. These are made by drug companies and are not sold as research powders.
- Bacteriostatic water
- Sterile water with a tiny amount of preservative, used to mix powdered peptides.
- Banned in drug-tested sport
- Prohibited by the World Anti-Doping Agency (WADA); using it can disqualify a competing athlete.
- Bioavailability
- How much of a dose actually reaches your bloodstream. Most peptides survive stomach acid badly, so most of them are injected instead of swallowed.
- Bioregulator
- Very short peptides from a Russian research tradition, usually two to four amino acids long, sold for supporting a specific organ. Human evidence is thin and most of it is published in Russian.
- Blend
- One vial holding more than one compound, mixed together by the seller. Working out a dose means working out each ingredient separately, because they are rarely present in equal amounts.
- Boxed warning
- The most serious warning the FDA puts on a drug label, printed inside a black border. It flags a risk considered severe enough to sit above everything else on the label.
- Bulks list
- The FDA's list of ingredients that compounding pharmacies are allowed to use. A substance can sit under review on it for years without anything being decided either way.
- Certificate of analysis (COA)
- A lab report on a batch of product. It only means something if it names the batch you actually received, comes from an independent lab, and can be checked with that lab.
- Clinical trial
- A study that gives a treatment to people under a written plan and measures what happens. It is the only kind of evidence that can show something works in humans.
- Compounding
- A licensed pharmacy preparing a medicine to order. Being allowed to compound something is not the same as the FDA approving it, and the two get mixed up constantly.
- Concentration
- How strong the mixed peptide is, in milligrams per milliliter (mg/mL). More water makes it weaker; less water makes it stronger.
- Cycle
- A stretch of time using a compound followed by a break. Most cycling patterns come from community practice. Very few have been tested.
- DAC
- Short for Drug Affinity Complex. An attachment added to a peptide so it grabs onto a blood protein and stays in the body for days instead of minutes.
- Dead space
- The small amount of liquid left sitting inside the needle and hub after you inject. On very small doses it can be a real share of what you meant to take.
- Dilute
- Adding more liquid to make a mix weaker. The amount of peptide in the vial does not change. It is just spread through more water, so each draw is bigger.
- Endpoint
- The result a trial said in advance that it would measure. A study can be reported as positive and still have missed the endpoint it set out to hit.
- FDA approved
- Reviewed by the FDA and cleared for a specific use, in a specific form, at a specific dose. Approval for one use is not approval for another, and approval in another country is not approval here.
- Fragment
- A short piece cut out of a larger natural protein. A fragment can behave very differently from the whole protein it came from, so evidence about one does not transfer to the other.
- Ghrelin
- The hunger hormone. Some growth hormone compounds work by copying it, so they can make you noticeably hungrier.
- GHRH
- A natural signal telling the pituitary gland to release growth hormone. Several compounds copy it.
- GHRP
- A second, separate signal that also triggers growth hormone release, through a different door than GHRH. This is why the two types are often used together.
- GLP-1
- A natural gut hormone that lowers appetite and blood sugar. Drugs that copy it, like semaglutide, are used for weight loss.
- Growth hormone secretagogue
- A compound that nudges your body to release more of its own growth hormone, rather than injecting the hormone itself.
- Half-life
- How long a compound stays active in your body. A longer half-life means you inject less often.
- HPLC
- A lab method that separates out everything in a sample so the amounts can be measured. It shows how much of the main ingredient is there. It does not confirm that the main ingredient is the right molecule.
- In vitro
- Done in a dish or a test tube, on cells outside a living body. It is the earliest kind of evidence there is.
- Injection site
- The spot on the body where you inject. Moving it around gives the skin and fat underneath time to recover between doses.
- Intramuscular (IM)
- An injection into a muscle, using a longer needle.
- Intravenous (IV)
- An injection into a vein. It needs training and equipment and is not something to do at home.
- Investigational
- Still being tested in clinical trials and not yet approved or legally sold for general use.
- Lyophilized
- Freeze-dried into a powder so it keeps longer. That is the white cake or dust in the bottom of an unmixed vial.
- Mass spectrometry
- A lab method that weighs molecules to confirm what they are. HPLC answers how much is in the sample. This answers what it is.
- mcg and mg
- Units of dose. 1 milligram (mg) equals 1,000 micrograms (mcg).
- Myostatin
- A natural brake on muscle growth. Several compounds are built to block it, though human results have been far smaller than the animal work suggested.
- Off-label
- A doctor prescribing an approved drug for something other than its approved use. This is legal and common, and it is different from a compound having no approval at all.
- Orphan drug designation
- A status given to treatments for rare conditions to make them worth developing. It is an incentive, not an approval, and a compound can hold it while being approved for nothing.
- PCAC
- The FDA advisory committee that reviews compounding ingredients. It recommends. It does not approve, and the FDA does not have to follow what it says.
- Peer review
- Other scientists checking a paper before a journal publishes it. It filters out some bad work. It does not make a finding true.
- Peptide vs small molecule
- A peptide is a short chain of amino acids. A few items here (like MK-677 or methylene blue) are small molecules, not true peptides, but people use them the same way.
- Placebo
- A dummy treatment given for comparison. Without one it is very hard to tell a real effect apart from expectation and time passing.
- Purity
- The share of a sample that is the intended compound, usually given as a percentage. A high purity number on the wrong molecule is still the wrong molecule.
- Randomized
- Deciding by chance who gets which treatment, so the two groups are comparable. Studies that skip this are much easier to read the wrong way.
- Receptor
- A docking point on a cell that a compound attaches to. If a cell has no matching receptor, the compound does nothing to it.
- Reconstitution
- Mixing a powdered peptide with liquid (bacteriostatic water) so it can be drawn into a syringe.
- Research only
- No approved dose or use in people. Sold for research and not reviewed by the FDA for safety or quality.
- Stack
- Using more than one compound at the same time. Almost no combinations have been tested together in people, so a stack is usually built on guesswork.
- Sterile water
- Water with nothing added to stop bacteria growing. It works for a single dose, but a vial mixed with it should not be kept and used again.
- Subcutaneous
- An injection just under the skin, into the fat layer, usually with a short, thin insulin needle.
- Titrate
- Starting at a low dose and increasing it slowly over time so your body adjusts and side effects stay mild.
- Trial phases
- The stages of human testing. Phase 1 checks safety in a small group, phase 2 looks for an effect, and phase 3 tests it against a comparison in a large group.
- Units (on the syringe)
- The marks on an insulin syringe. 100 units equals 1 mL. They measure how much liquid you draw, not the dose in milligrams.
Guides for this compound
- How to Reconstitute a Peptide
Mix peptide powder with bacteriostatic water, step by step.
- How to Read an Insulin Syringe
Read the units, convert to millilitres, and draw the exact dose.
- mcg vs mg: The Peptide Dosing Mistake to Avoid
Your vial says mg and your protocol says mcg. Here is the conversion and how to check it.
- Why Does My Peptide Injection Itch or Welt
Injection-site irritation, a histamine reaction, or a true allergy, and how to tell them apart.
- How to Read a Peptide COA
What the purity number does and does not tell you, and how to spot an edited report.
Sources
- PNAS, PNC-27 binds HDM-2 in cancer cell membranes(2010)Describes the mechanism in cell lines. Normal cells that were engineered to carry HDM-2 on their surface became vulnerable to the peptide, which supports the proposed target.
- PubMed, PNC-27 induces necrosis of a human leukaemia cell line(2014)Cell-line work extending the mechanism to a leukaemia line lacking p53.
Last reviewed 14 August 2026
Peptide Decoding is published by Decoded Sciences LLC. We take no payment from vendors for coverage, inclusion or ranking, and our affiliate relationships are disclosed in full.